Armetheon, Inc. is a privately held San Francisco Bay area based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced, successful biotech entrepreneurs and drug developers with funding from AshHill Biomedical investments (http://www.ashhill.net) and Atheneos Capital. Armetheon's two late-stage small molecule drug candidates are for use in the areas of oral anticoagulation and atrial fibrillation. Locust Walk Partners serves as the key strategic advisors to the company.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/28/14 | $7,000,000 | Series A |
AshHill Biomedical Investments Atheneos Capital Dr. Larry Hsu Hercules Bioventures | undisclosed |
